NEW YORK CITY (WABC) -- It could be a game changer in COVID 19 testing: A company with offices in the Tri-State area received emergency authorization from the FDA for a test that could get results ...

FDA-authorized test for home use is the most affordable PCR-quality rapid test on the market and at least 50 times more sensitive than leading rapid antigen tests Detect’s FDA authorized PCR-quality ...

EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...

3EO becomes the first point-of-care molecular technology to be retail priced below $15 per test. 3EO adds a breakthrough business model enabling more physician practices to upgrade technology from ...

The FDA has issued its first emergency use authorization for a COVID-19 molecular diagnostic test that does not require a prescription and can be used at home. Developed by Cue Health, the Cue ...

The U.S. Food and Drug Administration told consumers Monday to throw out any at-home COVID-19 tests made by San Diego biotech Cue Health, because they could give users false results. Early in the ...

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...

Type: COVID-19 test kits are categorized into equipment and extraction kits, rRT-PCR test kits, and reagents. Among these, rRT-PCR test kits, which enable the detection of viral RNA in respiratory ...

Finland's Nokia on Thursday reported a stronger than expected 38% rise in fourth-quarter adjusted operating profit helped by higher sales of telecom equipment to mobile operators in North America and ...

ZURICH, May 27 (Reuters) - Swiss drugmakers Novartis (NOVN.S), opens new tab and Molecular Partners (MOLN.S), opens new tab said on Thursday they will start clinical trials for an investigational ...